<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl2" position="float"><object-id pub-id-type="doi">10.7554/eLife.03925.005</object-id><label>Table 2.</label><caption><p>Relative risk of malaria infection after standard vaccination and vitamin A supplementation among children 6&#8211;59 months of age</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03925.005">http://dx.doi.org/10.7554/eLife.03925.005</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Type of immunization</th><th rowspan="2">No. of children vaccinated/total tested (%)</th><th colspan="2">No. of children with positive blood test (%)</th><th rowspan="2">Unadjusted RR</th><th align="center" colspan="2">Adjusted RR (95% CI)<xref ref-type="table-fn" rid="tblfn5">&#8225;</xref>,<xref ref-type="table-fn" rid="tblfn6">&#167;</xref></th></tr><tr><th>No vaccine</th><th>Vaccine</th><th align="center">Unweighted</th><th align="center">Weighted (IPW)</th></tr></thead><tbody><tr><td colspan="7">(a) <italic>Plasmodium</italic> species (parasitemia)<xref ref-type="table-fn" rid="tblfn3">*</xref></td></tr><tr><td>&#8195;Bacille Calmette Guerin (BCG)</td><td align="center">8013/8140 (98)</td><td align="center">41 (32)</td><td align="center">2227 (28)</td><td align="center">0.81</td><td align="center">1.25 (0.81&#8211;1.91)</td><td align="center">1.24 (0.76&#8211;2.05)</td></tr><tr><td>&#8195;Diphtheria&#8211;tetanus&#8211;pertussis (DTP)</td><td align="center">8044/8235 (98)</td><td align="center">83 (44)</td><td align="center">2202 (27)</td><td align="center">0.49</td><td align="center">0.88 (0.64&#8211;1.20)</td><td align="center">0.06 (0.01&#8211;0.47)</td></tr><tr><td>&#8195;Measles</td><td align="center">6450/8069 (80)</td><td align="center">473 (29)</td><td align="center">1784 (28)</td><td align="center">0.93</td><td align="center">1.11 (0.96&#8211;1.29)</td><td align="center">1.01 (0.20&#8211;5.19)</td></tr><tr><td>&#8195;Poliomyelitis</td><td align="center">8231/8272 (99)</td><td align="center">14 (34)</td><td align="center">2278 (28)</td><td align="center">0.74</td><td align="center">0.80 (0.37&#8211;1.73)</td><td align="center">0.74 (0.27&#8211;2.01)</td></tr><tr><td>&#8195;Vitamin A supplement</td><td align="center">2182/3523 (62)</td><td align="center">596 (44)</td><td align="center">438 (20)</td><td align="center">0.31</td><td align="center">0.46 (0.39&#8211;0.54)</td><td align="center">0.43 (0.36&#8211;0.52)</td></tr><tr><td colspan="7">(b) <italic>Plasmodium falciparum</italic> (antigenemia)</td></tr><tr><td>&#8195;Bacille Calmette Guerin (BCG)</td><td align="center">6006/6047 (99)</td><td align="center">9 (22)</td><td align="center">2102 (35)</td><td align="center">1.91</td><td align="center">4.06 (2.00&#8211;8.28)</td><td align="center">3.52 (1.66&#8211;7.48)</td></tr><tr><td>&#8195;Diphtheria&#8211;tetanus&#8211;pertussis (DTP)</td><td align="center">5933/6054 (98)</td><td align="center">59 (49)</td><td align="center">2049 (35)</td><td align="center">0.55</td><td align="center">1.34 (0.88&#8211;2.02)</td><td align="center">0.06 (0.01&#8211;0.38)</td></tr><tr><td>&#8195;Measles</td><td align="center">4776/5937 (80)</td><td align="center">410 (35)</td><td align="center">1679 (35)</td><td align="center">0.99</td><td align="center">1.15 (0.97&#8211;1.38)</td><td align="center">0.68 (0.15&#8211;3.12)</td></tr><tr><td>&#8195;Poliomyelitis</td><td align="center">6.072/6084 (99)</td><td align="center">5 (42)</td><td align="center">2111 (35)</td><td align="center">0.75</td><td align="center">1.39 (0.55&#8211;3.49)</td><td align="center">0.93 (0.37&#8211;2.35)</td></tr><tr><td>&#8195;Vitamin A supplement</td><td align="center">629/1749 (36)</td><td align="center">621 (56)</td><td align="center">75 (12)</td><td align="center">0.10</td><td align="center">0.23 (0.17&#8211;0.29)</td><td align="center">0.22 (0.16&#8211;0.29)</td></tr></tbody></table><table-wrap-foot><fn><p>HRP-2: histidine rich protein-2; RR: relative risk; CI: confidence interval; IPW: inverse probability weighted model.</p></fn><fn id="tblfn3"><label>*</label><p>Tested in four countries: Burkina Faso, Mozambique, Rwanda and Senegal.</p></fn><fn id="tblfn4"><label>&#8224;</label><p>Tested in three countries: Burkina Faso, Rwanda and Senegal.</p></fn><fn id="tblfn5"><label>&#8225;</label><p>Adjusted for the following factors: age, gender, wealth index score, mother's highest level of education, malaria treatment during previous week, ownership of bed net, proportion of household members under 5 years using bed net during previous night, indoor household insecticide spraying, mother's access to antenatal care during last pregnancy, mother's knowledge regarding vertical HIV transmission, malaria transmission season, and type of community setting (urban vs rural).</p></fn><fn id="tblfn6"><label>&#167;</label><p>Inverse probability weighting (IPW) based on propensity score model with following factors: age, gender, low birth weight, presence of radio or television, urban versus rural setting, breastfeeding status, wealth index score, mother's age, mother's highest education level, antenatal care during last pregnancy, and mother's tetanus status during last pregnancy.</p></fn></table-wrap-foot></table-wrap>